{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:47Z","timestamp":1790651987458,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2016YFC0901504"],"award-info":[{"award-number":["2016YFC0901504"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801196"],"award-info":[{"award-number":["81801196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771296"],"award-info":[{"award-number":["81771296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171341"],"award-info":[{"award-number":["82171341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.msard.2022.104023","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T12:12:00Z","timestamp":1657023120000},"page":"104023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China"],"prefix":"10.1016","volume":"66","author":[{"given":"Wenjuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzi","family":"ZhangBao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.104023_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577236","article-title":"Risk factors of attacks in neuromyelitis optica spectrum disorders","volume":"343","author":"Akaishi","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2022.104023_bib0002","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","article-title":"Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"268","author":"Akaishi","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.104023_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2017.12.019","article-title":"Chloride imbalance between serum and CSF in the acute phase of neuromyelitis optica","volume":"315","author":"Akaishi","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"18","key":"10.1016\/j.msard.2022.104023_bib0004","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2022.104023_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study","volume":"24","author":"Asgari","year":"2018","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2022.104023_bib0006","article-title":"AQP4-IgG autoimmunity in Japan and Germany: differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Multiple sclerosis journal - experimental","volume":"7","author":"Asseyer","year":"2021","journal-title":"Transl. Clin."},{"key":"10.1016\/j.msard.2022.104023_bib0007","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.12688\/f1000research.11401.1","article-title":"Chloride in intensive care units: a key electrolyte","volume":"6","author":"Bandak","year":"2017","journal-title":"F1000Res."},{"issue":"4","key":"10.1016\/j.msard.2022.104023_bib0008","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1212\/NXI.0000000000000580","article-title":"Neuromyelitis optica spectrum disorder: patient experience and quality of life","volume":"6","author":"Beekman","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.msard.2022.104023_bib0009","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.0b013e31824c466f","article-title":"Neuromyelitis optica and pregnancy","volume":"78","author":"Bourre","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2022.104023_bib0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s13167-018-0143-9","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies","volume":"9","author":"Borisow","year":"2018","journal-title":"EPMA J."},{"issue":"4","key":"10.1016\/j.msard.2022.104023_bib0011","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in South East Wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2022.104023_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.544434","article-title":"Pregnancy and neuromyelitis optica spectrum disorder - reciprocal effects and practical recommendations: a systematic review","volume":"11","author":"D'Souza","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2022.104023_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577494","article-title":"Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders","volume":"353","author":"Du","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.104023_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.585303","article-title":"Herpes zoster radiculomyelitis with aquaporin-4 antibodies: a case report and literature review","volume":"11","author":"Eguchi","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.104023_bib0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13760-018-0900-5","article-title":"Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study","volume":"118","author":"Eskandarieh","year":"2018","journal-title":"Acta Neurol. Belg."},{"issue":"4","key":"10.1016\/j.msard.2022.104023_bib0016","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaneurol.2013.6331","article-title":"Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4","volume":"71","author":"Figueroa","year":"2014","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.104023_bib0017","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.104023_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106606","article-title":"Sleep disorders as a possible predisposing attack factor in neuromyelitis optica spectrum disorder (NMOSD): a case-control study","volume":"204","author":"Haji Molla Rabi","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2022.104023_bib0019","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2022.104023_bib63","first-page":"1","article-title":"Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder","volume":"00","author":"Huang","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.msard.2022.104023_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102542","article-title":"Neuromyelitis optica spectrum disorder in China: quality of life and medical care experience","volume":"46","author":"Huang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2022.104023_bib0021","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1352458515572241","article-title":"Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4","volume":"21","author":"Iorio","year":"2015","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2022.104023_bib0022","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1352458515587752","article-title":"Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints","volume":"22","author":"Jeong","year":"2016","journal-title":"Mult. Scler."},{"issue":"14","key":"10.1016\/j.msard.2022.104023_bib0023","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2022.104023_bib0024","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1212\/WNL.0000000000007746","article-title":"Epidemiology of NMOSD in Sweden from 1987 to 2013: a nationwide population-based study","volume":"93","author":"Jonsson","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.104023_bib0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.msard.2017.08.005","article-title":"Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study","volume":"17","author":"Kessler","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"22","key":"10.1016\/j.msard.2022.104023_bib0026","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.msard.2022.104023_bib0027","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1212\/WNL.0000000000004681","article-title":"High risk of postpartum relapses in neuromyelitis optica spectrum disorder","volume":"89","author":"Klawiter","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2022.104023_bib0028","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"issue":"9451","key":"10.1016\/j.msard.2022.104023_bib0029","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.msard.2022.104023_bib0030","doi-asserted-by":"crossref","DOI":"10.15761\/CCRR.1000411","article-title":"Epstein - barr virus infection in a patient with neuromyelitis optica spectrum disorder and Sj\u00f6gren's syndrome: a case report and review of literature","volume":"4","author":"Levinson","year":"2018","journal-title":"Clin. Case Rep. Rev."},{"key":"10.1016\/j.msard.2022.104023_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.746959","article-title":"Serum aquaporin 4-immunoglobulin G titer and neuromyelitis optica spectrum disorder activity and severity: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2022.104023_bib0032","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fneur.2017.00062","article-title":"Different phenotypes at onset in neuromyelitis optica spectrum disorder patients with aquaporin-4 autoimmunity","volume":"8","author":"Long","year":"2017","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.104023_bib0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41582-020-0313-y","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations","volume":"16","author":"Mao-Draayer","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2022.104023_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102522","article-title":"Risk of relapse in patients with neuromyelitis optica spectrum disorder: recognition and preventive strategy","volume":"46","author":"Ma","year":"2020","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2022.104023_bib0036","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.msard.2018.05.003","article-title":"Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder","volume":"23","author":"Mealy","year":"2018","journal-title":"Mult. Scler. Relat. Disord"},{"issue":"3","key":"10.1016\/j.msard.2022.104023_bib0037","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.0b013e31825fdead","article-title":"Neuromyelitis optica following human papillomavirus vaccination","volume":"79","author":"Menge","year":"2012","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.msard.2022.104023_bib0039","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2169\/internalmedicine.50.5027","article-title":"Influenza-associated monophasic neuromyelitis optica","volume":"50","author":"Nakamura","year":"2011","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.msard.2022.104023_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","article-title":"Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"86","author":"Nour","year":"2016","journal-title":"Neurology"},{"issue":"10 Pt B","key":"10.1016\/j.msard.2022.104023_bib0041","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.bbamem.2014.09.001","article-title":"Key roles of aquaporins in tumor biology","volume":"1848","author":"Papadopoulos","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.msard.2022.104023_bib0042","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ene.14079","article-title":"A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary","volume":"27","author":"Papp","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"24","key":"10.1016\/j.msard.2022.104023_bib0043","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.msard.2022.104023_bib0044","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2013.07.2510","article-title":"A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster","volume":"334","author":"Park","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2022.104023_bib0045","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awz054","article-title":"Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders","volume":"142","author":"Palace","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.msard.2022.104023_bib0047","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.msard.2016.11.009","article-title":"NMOSD triggered by yellow fever vaccination - an unusual clinical presentation with segmental painful erythema","volume":"11","author":"Sch\u00f6berl","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"14","key":"10.1016\/j.msard.2022.104023_bib0048","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in Catalonia: influence of the new 2015 criteria in incidence and prevalence estimates","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.104023_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103227","article-title":"Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: a systematic review","volume":"56","author":"Shahmohammadi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.msard.2022.104023_bib0050","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/1352458515583376","article-title":"Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder","volume":"22","author":"Shimizu","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.104023_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103080","article-title":"Asian and African\/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence","volume":"53","author":"Soares-Dos-Reis","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.104023_bib0052","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jnnp-2017-315603","article-title":"Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response","volume":"88","author":"Stellmann","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.msard.2022.104023_bib0054","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2796.2007.01794.x","article-title":"Neuromyelitis optica following CMV primo-infection","volume":"261","author":"Tran","year":"2007","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.msard.2022.104023_bib0055","article-title":"Neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody: outcome prediction models","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2022.104023_bib0056","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jnnp-2020-323982","article-title":"Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors","volume":"92","author":"Wang","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.msard.2022.104023_bib0057","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.msard.2022.104023_bib0058","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2022.104023_bib0059","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.104023_bib0061","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/cns.12156","article-title":"Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China","volume":"20","author":"Yang","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.msard.2022.104023_bib0062","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2016.11.010","article-title":"The clinical characteristics of AQP4 antibody positive NMO\/SD in a large cohort of Chinese Han patients","volume":"302","author":"ZhangBao","year":"2017","journal-title":"J. Neuroimmunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822005314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822005314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:28:34Z","timestamp":1778840914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822005314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":58,"alternative-id":["S2211034822005314"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104023","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104023"}}